Pamela Engler
Medical · Castle Rock, CONPI 1679793178
Payments from drug & device makers
Across 160 payments — averaging $37.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Modernatx, Inc.$2K
- Novo Nordisk$666
- AbbVie$595
- Otsuka America Pharmaceutical, Inc.$345
- Alkermes, Inc.$295
- Amgen$234
- plus $2K from 29 others
What the payments were for
- Travel & lodging$1,55926%
- Food & beverage$4,47274%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Modernatx, Inc. | 8 | $2,082 |
| Novo Nordisk | 18 | $666 |
| AbbVie | 30 | $595 |
| Otsuka America Pharmaceutical, Inc. | 8 | $345 |
| Alkermes, Inc. | 9 | $295 |
| Amgen(2 entities) | 12 | $234 |
| Nevro Corp. | 7 | $207 |
| AstraZeneca | 10 | $181 |
| Idorsia Pharmaceuticals US Inc | 3 | $149 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $146 |
| Biohaven Pharmaceuticals, Inc. | 4 | $143 |
| Edwards Lifesciences | 2 | $136 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 6 | $110 |
| Pfizer | 5 | $99 |
| Bausch Health US, LLC | 3 | $57 |
| Jazz Pharmaceuticals Inc. | 3 | $53 |
| Lilly USA, LLC | 3 | $51 |
| Avanir Pharmaceuticals, Inc. | 3 | $50 |
| Neurocrine Biosciences, Inc. | 3 | $50 |
| Lundbeck LLC | 2 | $46 |
| Kowa Pharmaceuticals America, Inc. | 3 | $42 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $38 |
| Amarin Pharma, Inc. | 2 | $34 |
| Exact Sciences | 1 | $25 |
| Novartis | 1 | $23 |
| Corium, LLC | 1 | $23 |
| GSK | 1 | $22 |
| Dexcom, Inc. | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| Eisai Inc. | 1 | $19 |
| Boston Scientific | 1 | $18 |
| Therapeuticsmd, Inc. | 1 | $15 |
| Bardy Diagnostics, Inc. | 1 | $15 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $13 |
| Phathom Pharmaceuticals, Inc. | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$480
- NURTEC ODT$251
- Wegovy$243
- RYBELSUS$243
- REXULTI$234
- Creon$124
- QUVIVIQ$121
- Edwards SAPIEN 3 Transcatheter Heart Valve$100
How this compares
$6,031 in reported general payments places this provider in the 90th percentile of 766 medical providers in Colorado.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 17 | $38,270 |
| ProgesteroneProgesterone, Micronized | 23 | $1,013 |
| Gabapentin | 29 | $648 |
| Rosuvastatin Calcium | 53 | $543 |
| Olmesartan Medoxomil | 39 | $481 |
| Omeprazole | 25 | $465 |
| Levothyroxine Sodium | 47 | $415 |
| Atorvastatin Calcium | 48 | $415 |
| Pantoprazole Sodium | 14 | $393 |
| Escitalopram Oxalate | 17 | $302 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 12 | $263 |
| Amlodipine Besylate | 40 | $214 |
| Simvastatin | 13 | $155 |
| Zolpidem Tartrate | 14 | $122 |
| Lisinopril | 23 | $113 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $51 | $38,27017 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 766 medical providers in Colorado.
Other medical in Castle Rock
- Anthony CerulloCastle Rock$7K
- Christen KutzColorado Springs$2.4M
- Amanda MixonFort Collins$342K
- Kristin RyggColorado Springs$255K
- Jordan MastDenver$247K
- John NovakAurora$173K
- Michelle BarnettColorado Springs$138K
- Michael JacobsonFort Collins$131K
- Lindsey TunstallAurora$87K
- Jennifer NafzigerHighlands Ranch$80K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.